# Gıancarlo Comı

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/g-ancarlo-com/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,873 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 122 |
| i10-index | 682 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5043499649 |
| ORCID iD | https://orcid.org/0000-0002-6989-1054 |
| Works | 1,283 |

## Researcher papers

Showing 12 of 13.

- [Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis](https://scholariq.org/papers/genetic-risk-and-a-primary-role-for-cell-mediated-immune-mechanisms-in-multiple/)
- [Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis](https://scholariq.org/papers/analysis-of-immune-related-loci-identifies-48-new-susceptibility-variants-for/)
- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis](https://scholariq.org/papers/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple/)
- [Multiple sclerosis progression: time for a new mechanism-driven framework](https://scholariq.org/papers/multiple-sclerosis-progression-time-for-a-new-mechanism-driven-framework/)
- [Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-glatiramer-acetate-on-conversion-to-clinically-definite-multiple/)
- [Typical and atypical pathology in primary progressive aphasia variants](https://scholariq.org/papers/typical-and-atypical-pathology-in-primary-progressive-aphasia-variants/)
- [Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis](https://scholariq.org/papers/inflammation-triggers-synaptic-alteration-and-degeneration-in-experimental/)
- [Locus for severity implicates CNS resilience in progression of multiple sclerosis](https://scholariq.org/papers/locus-for-severity-implicates-cns-resilience-in-progression-of-multiple/)
- [Physiopathology and treatment of fatigue in multiple sclerosis](https://scholariq.org/papers/physiopathology-and-treatment-of-fatigue-in-multiple-sclerosis/)
- [Cell-based therapeutic strategies for multiple sclerosis](https://scholariq.org/papers/cell-based-therapeutic-strategies-for-multiple-sclerosis/)
- [Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls](https://scholariq.org/papers/network-based-multiple-sclerosis-pathway-analysis-with-gwas-data-from-15-000/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Advanced Neuroimaging Techniques and Applications](https://scholariq.org/topics/advanced-neuroimaging-techniques-and-applications/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.